Dropbox Demystified...
Health Care: Drugs
Optimer Pharmaceuticals Inc. (OPTR: NASDAQ)
$14.38 -0.05 | -0.35%
05/22/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 119.44M | 31.79M | 19.86M | 17.05M |
| Receivables | 9.51M | 58.85M | 53.55K | 84.16K |
| Inventories | 15.06M | 3.95M | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 152.02M | 177.16M | 49.93M | 38.60M |
| Property, Plant & Equipment, Gross | 6.33M | 6.19M | 4.29M | 4.26M |
| Accumulated Depreciation & Depletion | 1.99M | 3.60M | 3.59M | 3.58M |
| Property, Plant & Equipment, Net | 4.34M | 2.59M | 697.68K | 672.90K |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 2.18M | 2.27M | 1.39M | 1.38M |
| Total Non-Current Assets | 7.41M | 4.86M | 2.09M | 2.05M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 159.43M | 182.02M | 52.02M | 40.66M |
| Accounts Payable | 7.17M | 9.86M | 2.31M | 2.63M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 26.79M | 31.31M | 4.69M | 7.65M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 151.14K | 141.14K | 0.00 |
| Other Non-Current Liabilities | 1.83M | 0.00 | 0.00 | 253.47K |
| Minority Interest | -280.34K | -1.89M | -1.20M | -141.68K |
| Total Non-Current Liabilities | 1.83M | 6.81M | 2.14M | 3.29M |
| Total Liabilities | 28.62M | 38.12M | 6.83M | 10.94M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 130.81M | 143.90M | 45.19M | 29.71M |
| Common Par | 47.79K | 46.69K | 39.28K | 33.14K |
| Additional Paid In Capital | 382.28M | 358.90M | 267.67M | 205.11M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -251.98M | -214.99M | -222.81M | -175.47M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 464.17K | -46.72K | 298.85K | 38.06K |
| Total Capitalization | 130.81M | 143.90M | 45.19M | 29.71M |
| Total Equity | 130.81M | 143.90M | 45.19M | 29.71M |
| Total Liabilities & Stock Equity | 159.43M | 182.02M | 52.02M | 40.66M |
| Total Common Shares Outstanding | 47.79M | 46.69M | 39.28M | 33.14M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 47.33M | 45.62M | 37.83M | 32.47M |
| Diluted Weighted Shares Outstanding | 47.33M | 46.37M | 37.83M | 32.47M |
| Number of Employees | 281 | 278 | 87 | 69 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with OPTR
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
Latest OPTR Headlines from TheStreet
- Cubist, Optimer, Trius: Antibiotic Deal Making On Tap 05.22.13 | 07:05 am
- 3 Biotech Stocks Spiking With Big Volume 05.13.13 | 02:05 pm
- 3 Biotech Stocks Rising on Big Volume 02.27.13 | 02:02 pm
- 10 Biotech Stocks With A History Of Beating Earning Expectations 01.10.13 | 07:01 pm
- 5 Biotech Stocks Rising on Unusual Volume 11.20.12 | 02:11 pm
- 5 Stocks Moving Higher on Big Volume 09.04.12 | 02:09 pm
- Optimer Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript 07.31.12 | 10:07 pm
- Optimer Pharmaceuticals Inc. Stock Downgraded (OPTR) 05.17.12 | 05:05 am
- 5 Earnings Stocks Poised to Pop 05.09.12 | 10:05 am
- 7 Stocks Spiking on Unusual Volume 04.25.12 | 01:04 pm
Press Releases for OPTR
- Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire 03.15.13 | 08:03 am
- Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire 02.27.13 | 08:02 am
- Optimer Pharmaceuticals' Board Of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer - PR Newswire 02.27.13 | 08:02 am
- New Analysis Shows Age Has A Significant Effect On Outcomes In Patients Being Treated For Clostridium Difficile Infection (CDI) - PR Newswire 02.14.13 | 08:02 am
- Optimer Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year 2012 Financial Results - PR Newswire 02.07.13 | 08:02 am
- Optimer Pharmaceuticals To Present At Leerink Swann Global Healthcare Conference - PR Newswire 02.07.13 | 08:02 am
- Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire 02.01.13 | 08:02 am
- Optimer Pharmaceuticals Reports Preliminary 2012 Gross Product Sales Of $74.4 Million - PR Newswire 01.07.13 | 08:01 am
- Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire 12.24.12 | 08:12 am
- Optimer Pharmaceuticals To Present At The 31st Annual J.P. Morgan Healthcare Conference - PR Newswire 12.20.12 | 08:12 am
Partner Headlines for OPTR
- Optimer Pharmaceuticals Earnings: Everything You Must Know Now - Wall St. Cheat Sheet 05.09.13 | 07:05 am
- Narrower Loss at Optimer - Analyst Blog - Zacks 11.02.12 | 05:11 pm
- Pipeline Progress at Cubist Pharma - Analyst Blog - Zacks 11.01.12 | 06:11 pm
- Earnings Preview: Cubist Pharma - Analyst Blog - Zacks 10.17.12 | 09:10 am
- Optimer Pharma to Sell Optimer Bio Stake - Analyst Blog - Zacks 10.09.12 | 07:10 pm
- UPDATE: Oppenheimer Downgrades Optimer Pharmaceuticals to Perform on Near-Term Outlook - Benzinga 10.09.12 | 01:10 pm
- UPDATE: Morgan Stanley Initiates Optimer Pharmaceuticals at Underweight on Risk/Reward - Benzinga 10.04.12 | 01:10 pm
- How one bull is playing Optimer Pharma - NASDAQ 09.11.12 | 09:09 am
- Optimer's Dificid OK'd in Canada - Analyst Blog - Zacks 07.09.12 | 07:07 pm
- Optimer Earns Milestone Payment - Analyst Blog - Zacks 06.08.12 | 04:06 pm
